175 related articles for article (PubMed ID: 8227575)
1. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization.
De Santis M; Torricelli P; Cristani A; Cioni G; Montanari N; Sardini C; Ventura E; Romagnoli R
J Comput Assist Tomogr; 1993; 17(6):901-8. PubMed ID: 8227575
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization.
De Santis M; Alborino S; Tartoni PL; Torricelli P; Casolo A; Romagnoli R
Eur Radiol; 1997; 7(1):10-6. PubMed ID: 9000387
[TBL] [Abstract][Full Text] [Related]
3. [The magnetic resonance and histological correlations in hepatocellular carcinoma].
Bartolozzi C; Lencioni R; Caramella D; Paolicchi A; Russo R; Romani R
Radiol Med; 1994; 87(1-2):90-5. PubMed ID: 8128039
[TBL] [Abstract][Full Text] [Related]
4. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
6. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
9. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.
Rode A; Bancel B; Douek P; Chevallier M; Vilgrain V; Picaud G; Henry L; Berger F; Bizollon T; Gaudin JL; Ducerf C
J Comput Assist Tomogr; 2001; 25(3):327-36. PubMed ID: 11351179
[TBL] [Abstract][Full Text] [Related]
10. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
12. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.
Yan FH; Zhou KR; Cheng JM; Wang JH; Yan ZP; Da RR; Fan J; Ji Y
World J Gastroenterol; 2002 Aug; 8(4):658-62. PubMed ID: 12174374
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of hepatocellular carcinoma at 1.5 Tesla.
Rosenthal RE; Davis PL
Gastrointest Radiol; 1992; 17(1):49-52. PubMed ID: 1312048
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.
Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
World J Gastroenterol; 2004 Apr; 10(8):1152-6. PubMed ID: 15069716
[TBL] [Abstract][Full Text] [Related]
15. A Review Of Mri Appearances Of Lipiodol In Conventional Tace (Ctace) Treated Hepatocellular Carcinomas.
Khan ZA; Rana AI; Rauf M; Anwar J; Ali H; Afzal AA
J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S740-S745. PubMed ID: 38406903
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography.
Tsui EY; Chan JH; Cheung YK; Cheung CC; Tsui WC; Szeto ML; Lau KW; Yuen MK; Luk SH
Clin Imaging; 2000; 24(4):210-6. PubMed ID: 11274885
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI.
Kubota K; Hisa N; Nishikawa T; Fujiwara Y; Murata Y; Itoh S; Yoshida D; Yoshida S
Abdom Imaging; 2001; 26(2):184-90. PubMed ID: 11178697
[TBL] [Abstract][Full Text] [Related]
18. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
19. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
[TBL] [Abstract][Full Text] [Related]
20. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
